World First: HILAR™ technology promises mastitis-free cows without antibiotics

arrow_backTo the overview

19 November 2026 | FarmLaser ApS

Proven efficacy in Danish dairy barns.
A new field study from a test farm in Central and West Jutland shows a 72% reduction in somatic cell count (SCC) following treatment with Ledar™ M9 | Mastitis, compared to 38% in the control group. This effect is achieved with just two 3-minute treatments per week.

In 11 out of 12 cows, the somatic cell count dropped rapidly and in a statistically significant manner, with a median reduction of 82 percent.

“We are truly excited about this new treatment. It is fast and effective, and it makes perfect sense to avoid issues like withdrawal periods or having to discard milk with a high cell count. I believe farmers will certainly see the value in that,” says Niels Schultz, Sales Manager and co-founder of FarmLaser.

Mastitis is one of the costliest diseases in the Danish dairy industry, incurring losses through wasted milk, reduced yield, and the use of antibiotics. Ledar™ M9 | Mastitis fundamentally changes this equation: the milk remains free of antibiotics throughout the entire treatment and can be used for animal feed or human consumption, rather than ending up down the drain.

“HILAR™ technology delivers more energy directly into the inflamed tissue than we have ever been able to achieve with lasers. Consequently, we can now treat a cow in just three minutes—without antibiotics and without having to discard the milk,” says Janny Marie L. Peterslund, CEO and co-founder of FarmLaser.

What is HILAR™ technology?
High Intensity Light Array (HILAR™) is a new innovation that combines advanced LED units with optical lenses. This optical core delivers high-energy, focused light deep into the tissue, triggering photobiomodulation (PBM)—a proven therapeutic method that inhibits inflammation, increases blood flow, and repairs damaged tissue.

Because the system utilizes an advanced LED-optical lens array rather than a laser, it is more energy-efficient and capable of delivering higher power output without compromising battery life.

HILAR™ technology offers:
Faster treatment: 1–3 minutes, compared to 6–12 minutes with traditional laser technology.
Larger treatment area: Four times larger than comparable lasers—12 cm², the largest on the market.
Enhanced safety: A significantly lower risk of eye injury to staff and animals compared to laser devices.
Ease of use: A compact, cordless unit—no heavy battery packs—designed for one-handed operation.
Send feedback

This article is written by:

FarmLaser ApS

FarmLaser ApS sells products for the antibiotic-free treatment of mastitis in dairy cattle, as well as a wide range of infections and inflammatory conditions in cattle, pigs, sheep, and goats.

Our technologies promote animal welfare, reduce antibiotic usage, and create a sustainable balance between humans, animals, and the environment.

Ledar™ M9 | Mastitis, featuring brand-new HILAR™ technology, effectively treats clinical and subclinical mastitis, chronic mastitis, and udder edema, while also stimulating milk let-down. The device has been tested on Danish dairy farms in close collaborat

See profile

Meet us at Agromek 2026

Janny Marie L Peterslund

CEO

FarmLaser ApS

At the exhibition

Janny Marie L Peterslund

Nina Jebens

Farm Operations Specialist

FarmLaser ApS

At the exhibition

Nina Jebens

Niels Schultz

Director of Sales

FarmLaser ApS

At the exhibition

Niels Schultz

Claus Elmann

Data & Knowledge

FarmLaser ApS

At the exhibition

Claus Elmann

Mads Daugaard

CSO

FarmLaser ApS

At the exhibition

Mads Daugaard

Casper Dolleris

CTO

FarmLaser ApS

At the exhibition

Casper Dolleris

Responsibility for content on this site

Information, images, product descriptions, videos, certifications, sustainability claims, and other content on company profiles are uploaded and maintained by the individual exhibitors.

Exhibitors are solely responsible for ensuring that their content is accurate, properly documented, and legally compliant, including compliance with applicable regulations concerning marketing, sustainability claims, and intellectual property rights.

MCH A/S solely provides the platform and does not, as a general rule, verify the content.